Drugs / Aceclofenac
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT05558150 | Nov → Dec 2022 | — | Il-Yang Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT05181124 | Mar 2021 | active peptic ulcer disease | Onconic Therapeutics Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03127046 | Mar → Apr 2017 | — | Dong Wha Pharmaceutical Co. Ltd. | Unknown | No outcome recorded |
| Phase 1 | NCT01869985 | Aug → Sep 2013 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT03146481 | Jul 2016 → Jul 2017 | pulpitis | Cairo University | Completed | No outcome recorded |
| Phase 2/3 | NCT03335007 | May 2015 → Jul 2017 | pulpitis | Cairo University | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT00635349 | May 2007 → Apr 2009 | osteoarthritis | Janssen Korea, Ltd., Korea | Completed | No outcome recorded |
| Phase 4 | NCT04144101 | Mar → Jul 2007 | rheumatoid arthritis | Chung Shan Medical University | Completed | No outcome recorded |
| Comparator or background therapy11 trials | ||||||
| Phase 1 | NCT05237297 Comparator | Feb → Jul 2022 | — | Il-Yang Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT04639804 Comparator | Jun → Jul 2020 | — | HK inno.N Corporation | Completed | No outcome recorded |
| Phase 1 | NCT02289274 Comparator | Nov → Dec 2019 | — | NVP Healthcare | Withdrawn | No outcome recorded |
| Phase 3 | NCT01952314 Comparator | May 2014 → Aug 2015 | ureterolithiasis | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01959074 Comparator | May 2014 → Jun 2015 | urinary system disorder | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02682524 Comparator | Aug 2015 → Mar 2016 | osteoarthritis, knee | Daewon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT01912066 Background | Sep 2012 → Mar 2014 | gastroduodenitis | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT00647517 Background | Mar 2008 → Jul 2009 | ankylosing spondylitis | Chung Shan Medical University | Completed | No outcome recorded |
| — | NCT05980572 Background | Sep 2022 → Oct 2023 | frozen shoulder | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| — | NCT02883569 Background | Sep 2016 → Dec 2020 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT02384928 Comparator | Sep 2015 → Jan 2017 | lumbar disk disease, sciatica | Jaseng Medical Foundation | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 20 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aceclofenac | “Tramadol 37.5 mg/APAP 325 mg combination tablets (Ultracet®) one tablet twice a day plus aceclofenac tablet per oral 100 mg twice a day.” NCT00647517 ↗18“aceclofenac (Drug class: nonsteroidal antiinflammatoy drugs (NSAIDs))” NCT02384928 ↗ “Aceclofenac 100mg or tramadol37.5mg/acetaminophen 325mg on demand” NCT01952314 ↗ “Eperisone SR and aceclofenac” NCT02289274 ↗ “aceclofenac 100mg on demand” NCT01959074 ↗ “Aceclofenac 100mg Tablet” NCT01869985 ↗ |
| Known as | Aceclofenac betadex | ChEMBL registry synonym — accepted as the source's own label CHEMBL93645 ↗ |
| Known as | Aceclofenaco | ChEMBL registry synonym — accepted as the source's own label CHEMBL93645 ↗ |
| Known as | Acrofen | “A tablet of DA9601, Cytotec (200ug of Misoprostol), Acrofen (100mg of Aceclofenac) will be assigned randomly to the subjects for four weeks.” NCT01912066 ↗ |
| Known as | Gerbin | ChEMBL registry synonym — accepted as the source's own label CHEMBL93645 ↗ |
| Known as | Preservex | ChEMBL registry synonym — accepted as the source's own label CHEMBL93645 ↗ |
| Action | Inhibit | “Cyclooxygenase-2 inhibitor” CHEMBL93645 ↗ |
| Modality | Small molecule | — CHEMBL93645 ↗ |
| Route | Oral | “aceclofenac tablet per oral 100 mg twice a day” NCT00647517 ↗ |
| Target | PTGS2 | “Cyclooxygenase-2 inhibitor” CHEMBL93645 ↗ |